Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033774 (
pruritus
)
14,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This report describes an extremely rare case of occupational allergy that developed in a frog handler. A 31-year-old female laboratory technician developed
itching
and urticaria one year after she began handling frogs and extracting their brains in the laboratory. Nine years later she noticed swelling of the right hand, stridor and
dyspnea
when she mistakenly injected her finger with a needle contaminated with extracts of frog brain. Specific IgE antibody to frog extracts was demonstrated by RAST and by P-K testing. However, no specific IgG antibody was found by agar gel diffusion or in heterologous PCA testing using guinea pigs. We suggest that allergic symptoms in this case were due to the development of Type I allergic reactivity to frog antigens.
...
PMID:A new occupational allergy due to frogs. 660 74
A 39-year-old nurse exhibited for one year an immediate-type asthmatic reaction with rhinorrhea and facial flushing and
itching
after ingestion of alcohol. The elimination of all alcohol-containing items from the operating theater brought relief from the daytime symptoms. Some
dyspnea
after salicylate ingestion and in cold weather persisted. Oral provocation tests with wine and pure ethanol and inhalation tests with ethanol vapours gave rise to all the known symptoms. Asthma could be prevented by prior inhalation of disodium cromoglycate, whereas facial
itching
and nasal reaction was prevented by oral ketotifen but not by cromoglycate.
...
PMID:[Asthma and rhinitis induced by the ingestion of pure ethanol and by the inhalation of alcohol vapors]. 680 72
This communication describes the first known report of sulindac-induced anaphylaxis. A 17-year-old patient who ingested a single tablet of sulindac developed
pruritus
, hives, and
dyspnea
. Blood pressure was not detectable. The patient was treated with epinephrine, a corticosteroid, and an antihistamine. Recovery was complete. The ability of this class of drugs to produce dangerous reactions is discussed.
...
PMID:Sulindac-induced anaphylaxis. 746 57
We describe the case of a 36 ys aged woman complaining of symptoms of oculorhinitis with
itching
, occasional
dyspnea
and laryngeal constriction. The patient related her symptoms with the emission of dusts and steam from a factory in the neighbourhood producing manufactures using polyester resins dissolved in styrene. No bronchospastic response was obtained after challenge with methacoline and ultrasonic nebulization of distilled water, which instead provoked a significant increase of nasal resistance. The inhalation challenge with styrene produced a dual nasal response. To our knowledge this is the first case of non occupational neighbourhood rhinitis provoked by styrene.
...
PMID:[A new environmental pathology: styrene-induced rhinitis]. 772 Sep 59
In a prospective study, the prevalence of 15 physical symptoms and symptom groups was evaluated in 1635 cancer patients referred to a pain clinic. In addition to pain, patients suffered an average of 3.3 symptoms: insomnia (59%), anorexia (48%), constipation (33%), sweating (28%), nausea (27%),
dyspnea
(24%), dysphagia (20%), neuropsychiatric symptoms (20%), vomiting (20%), urinary symptoms (14%), dyspepsia (11%), paresis (10%), diarrhea (6%),
pruritus
(6%), and dermatological symptoms (3%). While symptom prevalence was influenced by tumor site, pain intensity, and opioid treatment, only a minor relationship was seen between symptoms and gender, age, or tumor stage. The data emphasize that it is not sufficient to simply address pain during the treatment of patients with cancer pain; a more global approach to symptom management is necessary.
...
PMID:Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. 796 90
An increased hematocrit can be caused by primary proliferative polycythemia (PPP), by secondary polycythemia, by relative polycythemia (reduced plasma volume with a normal red cell mass), or by modifications of the red cell mass and the plasma volume within their normal ranges. As an increased hematocrit by itself is a risk factor for thrombosis, it is important to diagnose not only polycythemia, but also its possible cause, in order to offer optimal therapy. Smoking is the most frequent cause of an increased hematocrit. Splenomegaly, aquagenic
pruritus
, and erythromelalgia often exist in PPP, whereas other symptoms such as
dyspnea
are more likely to be associated with secondary polycythemia. Smokers with an increased hematocrit will be asked to stop smoking before ordering blood volume studies. These studies are not indicated in patients with obvious pulmonary disease. Male patients with an hematocrit over 60% and female patients with an hematocrit over 55% always have absolute polycythemia. The associations of an increased hematocrit with splenomegaly, a raised white blood cell count or thrombocytosis are indicators for PPP. The necessity for blood volume studies is questionable in these patients. However, blood volume studies are useful in patients with an increased hematocrit and no other clinical or biological signs suggestive of any form of polycythemia.
...
PMID:What clinical and laboratory data are indicative of polycythemia and when are blood volume studies needed? 803 31
We studied the relation between the amount of textile and other soft fiber wall materials used in the office and the symptoms related to sick building syndrome in two identical, mechanically ventilated, eight-story office buildings. The study population consisted of 400 workers (85% of the source population): 264 males (66%) and 136 females (34%). A self-administered questionnaire inquired about the occurrence of symptoms and related personal and environmental determinants. The office environment was assessed concurrently. Exposure was defined as the surface area of textile or other soft wall material (SWM) in the office. The outcomes were formed using the 7-d prevalences of individual symptoms, including mucosal irritation score (eye irritation, nasal dryness, nasal congestion, pharyngeal irritation); allergic reaction score (eye irritation, nasal congestion, nasal excretion, sneezing); asthma reaction score (wheezing,
breathlessness
, cough); skin reaction score (dryness,
itch
, or irritation, rash); and general symptom score (headache, lethargy). In the logistic regression controlling for potential confounders, the adjusted odds ratio for the symptoms of mucosal irritation was 1.82 (95% confidence interval [95% CI] = 1.14, 2.90) in the low-exposure group, compared with the unexposed reference group; and 2.46 (95% CI = 1.15, 5.28) in the high-exposure group, compared with the reference group. Corresponding odds ratios for the symptoms of allergic reaction were 1.82 (95% CI = 1.14, 2.90) and 3.16 (95% CI = 1.41, 7.09). No difference was found in the risk for asthmatic or skin reactions or general symptoms. The results support a hypothesis that textile and other soft-fiber wall materials used in the office environment are possible determinants of sick building syndrome.
...
PMID:Textile wall materials and sick building syndrome. 818 88
A case of anaphylactoid transfusion reaction associated with anti-IgA antibodies is reported. The patient had low levels of serum IgA. She developed serious reaction characterised by erythematous rash,
pruritus
, cyanosis and
dyspnoea
after transfusion of otherwise compatible blood. Review of literature reveals that anaphylactoid transfusion reactions are very rare although frequency of anti-IgA in general population is quite high. The IgA deficient donors (aIgA) form a unique resource of blood components for the clinical management of patients with anaphylactoid reactions caused by anti-IgA.
...
PMID:Anaphylactoid transfusion reaction with anti-IgA antibodies in an IgA deficient patient: a case report. 830 Jan 76
Seven women and one man aged from 51 to 70 years suffered from eosinophilia-myalgia syndrome after taking medicines containing tryptophan for depression or sleep disorders; the total duration of intake ranged from three to 106 months and the average daily dose was 1312 mg. All the patients had muscle pains and skin lesions resembling scleroderma together with impairment of general well being; six of them had high eosinophil counts of up to 2,600 cells/microliters (mean 1,629); other symptoms were weight loss,
pruritus
, fever,
dyspnoea
and sensory abnormalities. Discontinuation of tryptophan combined with systemic treatment with prednisone in doses of 32 or 20 mg/d for 4 to 16 weeks soon brought the eosinophil counts down, but the skin lesions, muscle pains and other symptoms showed little improvement over a follow-up period averaging 17.1 months. Treatment with penicillin G (20 mega-units daily for 14 days), azathioprine (100 mg daily for 2 months) or cyclosporin (2.5 mg/kg.day) was tried in some cases but had no significant effect.
...
PMID:[The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients]. 844 Jan 61
The idiopathic hypereosinophilic syndrome (HES) is an infrequent entity defined by an eosinophil count > 1.5 x 10(9)/l and the specific infiltration of different organs not attributable to another disease. Its prognosis is marked by the complications derived from visceral, particularly cardiac, infiltration determining a median survival of less than one year if treatment is not administered. Although a notable prolongation in survival may be achieved in these patients with the administration of glucocorticoids and cytolytic drugs, mainly hydroxiurea, there remains a group of patients who do not respond to these therapeutic measures, thus leading to alpha interferon trials with promising results. A favourable experience with the use of alpha interferon in two patients with IHS resistant to conventional treatment is reported. The first patient presented a picture characterized by diarrhoea, palpitations and effort
dyspnea
demonstrating heart involvement suggestive of eosinophilic infiltration on echocardiographic study. The second patient presented dyspneic night cough and generalized
pruritus
in addition to anemia and thrombocytopenia. The administration of alpha interferon (3 x 10(6) U/3 days a week and 3 x 10(6) U/day, respectively) was followed in both cases by the rapid disappearance of the symptomatology, normalization of the hematologic parameters and a reduction of the eosinophilia to values of less than 1 x 10(9)/l. This response has maintained over the two years of control in which the patients have received alpha interferon as a maintenance treatment.
...
PMID:[Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy]. 866 89
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>